Enhancingin vivo effect of propranolol on human lymphocyte function is not due to stereospecific beta-adrenergic blockade
- 1 January 1993
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 38 (1-2) , 281-285
- https://doi.org/10.1007/bf01976221
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The membrane stabilizing and β1-adrenoceptor blocking activity of (+)- and (−)-propranolol on the rat left atriaGeneral Pharmacology: The Vascular System, 1990
- Beta‐Adrenoceptor Antagonist‐Induced Psoriasiform EruptionInternational Journal of Dermatology, 1988
- The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseImmunology Today, 1988
- Alpha2-adrenoceptors in human lymphocytes: Direct characterisation by [3H]yohimbine bindingBiochemical and Biophysical Research Communications, 1984
- Immunoregulation by sympathetic nervous systemTrends in Pharmacological Sciences, 1981
- Antinuclear Antibodies and Cardiovascular DrugsDrugs, 1980
- Beta adrenergic receptors in lymphocyte subpopulationsJournal of Allergy and Clinical Immunology, 1980
- Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.Journal of Clinical Investigation, 1976
- Modulation of Inflammation and Immunity by Cyclic AMPScience, 1974
- Systemic Lupus Erythematosus Syndrome Induced by PractololBMJ, 1973